PL329053A1 - Novel derivatives of oxazolydine, method of obtaining them and therapeutic agents containing such compounds - Google Patents

Novel derivatives of oxazolydine, method of obtaining them and therapeutic agents containing such compounds

Info

Publication number
PL329053A1
PL329053A1 PL97329053A PL32905397A PL329053A1 PL 329053 A1 PL329053 A1 PL 329053A1 PL 97329053 A PL97329053 A PL 97329053A PL 32905397 A PL32905397 A PL 32905397A PL 329053 A1 PL329053 A1 PL 329053A1
Authority
PL
Poland
Prior art keywords
oxazolydine
compounds
obtaining
therapeutic agents
agents containing
Prior art date
Application number
PL97329053A
Other languages
English (en)
Inventor
Christos Tsaklakidis
Liesel Doerge
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19612827A external-priority patent/DE19612827A1/de
Priority claimed from DE1996154479 external-priority patent/DE19654479A1/de
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of PL329053A1 publication Critical patent/PL329053A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL97329053A 1996-03-30 1997-03-26 Novel derivatives of oxazolydine, method of obtaining them and therapeutic agents containing such compounds PL329053A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19612827A DE19612827A1 (de) 1996-03-30 1996-03-30 Neue Oxazolidinonderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1996154479 DE19654479A1 (de) 1996-12-27 1996-12-27 Neue Oxazolidinderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
PCT/EP1997/001542 WO1997036899A1 (de) 1996-03-30 1997-03-26 Neue oxazolidinderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
PL329053A1 true PL329053A1 (en) 1999-03-01

Family

ID=26024325

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97329053A PL329053A1 (en) 1996-03-30 1997-03-26 Novel derivatives of oxazolydine, method of obtaining them and therapeutic agents containing such compounds

Country Status (16)

Country Link
EP (1) EP0891359A1 (de)
JP (1) JP2000510445A (de)
KR (1) KR20000005117A (de)
CN (1) CN1219933A (de)
AR (1) AR006452A1 (de)
AU (1) AU722747B2 (de)
BR (1) BR9708475A (de)
CA (1) CA2250250A1 (de)
CZ (1) CZ305198A3 (de)
HU (1) HUP9901741A3 (de)
IL (1) IL126390A0 (de)
NO (1) NO984547L (de)
NZ (1) NZ332245A (de)
PL (1) PL329053A1 (de)
TR (1) TR199801961T2 (de)
WO (1) WO1997036899A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999032486A1 (en) * 1997-12-23 1999-07-01 Alcon Laboratories, Inc. Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
WO2002074762A1 (fr) * 2001-03-15 2002-09-26 Takeda Chemical Industries, Ltd. Procede relatif a l'elaboration de derive sulfone
EP1598340B1 (de) * 2001-04-18 2009-03-04 Euro-Celtique S.A. 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivate und verwandte verbindungen als nociceptin analoge und orl1 liganden zur behandlung von schmerz
JPWO2003095446A1 (ja) * 2002-05-09 2005-09-15 持田製薬株式会社 1−(4−ピリジル)−4−ピペリドンの製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9122016D0 (en) * 1991-10-16 1991-11-27 Glaxo Group Ltd Chemical compounds
AU2915892A (en) * 1991-11-14 1993-06-15 Glaxo Group Limited Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
WO1993014077A1 (en) * 1992-01-21 1993-07-22 Glaxo Group Limited Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
ATE181735T1 (de) * 1993-05-01 1999-07-15 Merck Patent Gmbh Substituierte 1-phenyl-oxazolidin-2-on derivate, deren herstellung und deren verwendung als adhäsionsrezeptor-antagonisten
DE19524765A1 (de) * 1995-07-07 1997-01-09 Boehringer Mannheim Gmbh Neue Oxazolidinonderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
CN1219933A (zh) 1999-06-16
NO984547D0 (no) 1998-09-29
NO984547L (no) 1998-11-30
AU2505697A (en) 1997-10-22
EP0891359A1 (de) 1999-01-20
HUP9901741A3 (en) 2000-03-28
HUP9901741A2 (hu) 1999-09-28
NZ332245A (en) 2000-03-27
AR006452A1 (es) 1999-08-25
KR20000005117A (ko) 2000-01-25
AU722747B2 (en) 2000-08-10
TR199801961T2 (xx) 1999-01-18
CZ305198A3 (cs) 1999-02-17
JP2000510445A (ja) 2000-08-15
IL126390A0 (en) 1999-05-09
BR9708475A (pt) 1999-04-13
CA2250250A1 (en) 1997-10-09
WO1997036899A1 (de) 1997-10-09

Similar Documents

Publication Publication Date Title
PL328771A1 (en) Derivatives of 4-aminopyrimidine, therapeutic agents containing such compounds, their application and method of obtaining such compounds
PL317930A1 (en) Oxalydine compounds, method of obtaining them and therapeutic agents
PL321201A1 (en) Derivatives of 4-hydroxypiepridine, method of obtaining them and therapeutic agents containing such derivatives
PL330841A1 (en) Benzosulphonic derivatives, method of obtaining them and therapeutic agents containing such derivatives
PL329440A1 (en) Derivatives of d-proline, method of obtaining them and therapeutic agent containing such compounds
PL320952A1 (en) Cycloalkanon pyridines, method of obtaining and therapeutic agents containing them
PL311999A1 (en) Piperazine derivatives, therapeutic agents containing them and method of obtaining such derivatives
PL313433A1 (en) Derivatives of benzazepin-, benzoxazepin- and benzothiazepin-n-acetic acids, method of obtaining them and therapeutic agents containing such derivatives
PL318277A1 (en) Novel substituted axazolydinones, method of obtaining and drugs containing them
PL332432A1 (en) Oxadiazoles, method of obtaining them as well as their application as therapeutic agents
PL316613A1 (en) Novel derivatives of piperazine, methods of obtaining them and agents containing such derivatives
PL333364A1 (en) Novel compounds and method of using them
PL324436A1 (en) Novel derivatives of oxazolydinone, method of obtaining them and therapeutic agents containing such compounds
PL331863A1 (en) 7alpha-(xi-aminoalkyl)-estrathienes, method of obtaining them, pharmacautic preparations containing such compounds and their application in production of therapeutic agents
PL324571A1 (en) 8-substituted derivatives of 1,3,8-triazaspiro[4,5]dekan-4-one, method of obtaining them and therapeutic agents containing such compounds
PL307669A1 (en) Benzimidazoles, therapeutic agents containing them and method of obtaining such compounds
PL325322A1 (en) Novel substituted amine compounds, method of obtaining them and therapeutic agent
GB9715295D0 (en) Novel method of treatment
PL322802A1 (en) Derivatives of 10,13,15-trioxatricyclo[9.2.1.1]-pentadecanone, method of obtaining them and therapeutic agents containing such compounds
GB9712866D0 (en) Novel method of treatment
GB9707693D0 (en) Novel method of treatment
PL316486A1 (en) Novel sulphonamides, method of obtaining them and therapeutic agent containing them
PL330257A1 (en) Novel heterocyclic derivatives of benzocycloalkene, method of obtaining them and therapeutic agent
PL324588A1 (en) Novel compounds-substituted piperydinodiones-2,6, method of obtaining them and drug containing such compounds
GB9715298D0 (en) Novel method of treatment